CV Risk Higher with Sulfonylureas than Metformin - Renal and Urology News
Links shared publicly online about this topic.
- 188total visits
CV Risk Higher with Sulfonylureas than Metformin - Renal and Urology News
SAN DIEGO—Older patients with type 2 diabetes have a significantly higher likelihood of experiencing a cardiovascular (CV) event within two years if they start treatment with a sulfonylurea drug than with metformin, researchers reported at the 71st Scientific Sessions of the American Diabetes Association.
View full resource at renalandurologynews.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Kidney Health, Urinary System, Glucophage, Urology
Most Recently Shared on June 27, 2011 at 6:00 pm By:
CV Risk Higher with Sulfonylureas than Metformin: SAN DIEGO—Older patients with type 2 diabetes have a significa... http://bit.ly/iMCerb
Advertisement
